IPO News Archive
1 IPO planned for the week of Mar 1
2/28/10
Anthera Pharmaceuticals, which is developing anti-inflammatory therapies for acute coronary syndrome and lupus, plans to raise $42 million by offering 6 million shares at a price of $7 per share, according to a post-effective amendment filed on Friday. Venture backers have indicated an interest in purchasing almost 37% of the deal, or 2.2 million shares. The biotech had originally planned to offer 4.6 million shares at a price range of $13-$15. Under the newly revised terms, Anthera Pharmaceuticals will command a market value of $151 million. Anthera, which was founded in 2004, has yet to generate product revenue and is set to launch a Phase 3 trial for its lead product candidate. The Hayward, CA-based company plans to list on the NASDAQ under the symbol ANTH. Deutsche Bank is the lead underwriter on the deal, which is expected to price on Monday, Mar. 1.
Source: www.RenaissanceCapital.com
Latest User Comments
will this get done? 2/26/2010 11:40:31 AM
Posted by: Opul
Thoughts on Anthera actually pricing their IPO? Now it''s pushed into next week. Although there has been some other biotech activity - two new deals added to the calendar for later in March....